Company: NIVFW
Filing Date: 2025-10-31
Form Type: 424B3
Source: 0001213900-25-104469
Chunk: 250

Company: NewGenIvf Group Ltd
Filing Date: 2025-10-31
Form: 424B3
Chunk 250
---
 204,000 |   |     |      | (8,892,956 | ) |
| Equity line of Credit                                                                    |     |                          |  9,181,273 |   |     |      |            |   |
| Convertible promissory note                                                              |     |                          |          — |   |     |      |  3,380,990 |   |
| Net cash (used in)/provided by financing activities                                      |     |                          |  9,963,297 |   |     |      | (4,352,923 | ) |
| Net (decrease)/increase in cash and cash equivalents                                     |     |                          |  1,525,447 |   |     |      |   (154,677 | ) |
| Effect of foreign currency translation on cash and cash equivalents                      |     |                          |   (374,711 | ) |     |      |    284,681 |   |
| Cash and cash equivalents, beginning of period                                           |     |                          |    457,740 |   |     |      |     54,104 |   |
| Cash and cash equivalents, end of period                                                 |     | $                        |  1,608,476 |   |     | $    |    184,109 |   |

<div align='center'>The accompanying notes are an integral part of
these unaudited condensed consolidated financial statements.

F-37

NEWGENIVF GROUP LIMITED
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
FOR THE SIX MONTHS ENDED JUNE 30, 2025 AND DECEMBER 31, 2024
(Stated in US Dollars)</div>

NOTE 1 — ORGANIZATION AND PRINCIPAL ACTIVITIES

Prior to the Business Combination,
on April 29, 2021, A SPAC I Acquisition Corp. (“ASCA”), was incorporated as a British Virgin Islands business company, specifically
a blank check company formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, recapitalization,
reorganization or similar business combination with one or more target businesses.

The Business Combination

On February 15, 2023, ASCA
entered into the Merger Agreement (as amended on June 12, 2023 and December 6, 2023, the “Merger Agreement,” and the transactions
contemplated thereunder, the “Business Combination”) with